Metastasis-directed Therapy in solitary oligorecurrent Prostate Cancer without Androgen Deprivation Therapy - a Commentary

被引：0
|
作者：
Falkenbach, Fabian [1 ,3 ]
Maurer, Tobias [1 ,2 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Martini Klin Prostatakarzinomzentrum, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Urol, Hamburg, Germany
[3] Univ Klinikum Hamburg Eppendorf, Martini Klin Prostatakarzinomzentrum, Martinistr 52, D-20246 Hamburg, Germany
来源：
UROLOGIE | 2023年 / 62卷 / 04期
关键词：
PREDICTORS; RECURRENCE; DIAGNOSIS; PET/CT;
D O I：
10.1007/s00120-023-02050-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 406
页数：3
相关论文
共 50 条
  • [1] Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer
    Andrews, Jack R.
    Ahmed, Mohamed E.
    Sharma, Vidit
    Britton, Cameron
    Stish, Bradley
    Phillips, Ryan
    Kendi, A. Tuba
    Joshi, Vidhu B.
    Sood, Akshay
    Tollefson, Mathew K.
    Boorjian, Stephen A.
    Karnes, R. Jeffery
    Kwon, Eugene D.
    JOURNAL OF UROLOGY, 2022, 208 (06): : 1240 - 1249
  • [2] Metastasis-directed therapy for oligorecurrent prostate cancer: a pooled analysis
    Ost, P.
    Berlin, A.
    Siva, S.
    Reynders, D.
    Phillips, R.
    Glicksman, R.
    Faroudi, F.
    Fonteyne, V.
    Deek, M.
    Chung, P.
    Murphy, D.
    Tran, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1128 - S1128
  • [3] Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance
    Triggiani, Luca
    Mazzola, Rosario
    Tomasini, Davide
    Bruni, Alessio
    Alicino, Giulia
    Matrone, Fabio
    Bortolus, Roberto
    Francolini, Giulio
    Detti, Beatrice
    Magli, Alessandro
    Bonu, Marco Lorenzo
    Ingrosso, Gianluca
    Lancia, Andrea
    Trippa, Fabio
    Maranzano, Ernesto
    Franzese, Ciro
    Ghirardelli, Paolo
    Vavassori, Vittorio
    Scorsetti, Marta
    Alongi, Filippo
    Magrini, Stefano Maria
    MEDICAL ONCOLOGY, 2021, 38 (06)
  • [4] Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance
    Luca Triggiani
    Rosario Mazzola
    Davide Tomasini
    Alessio Bruni
    Giulia Alicino
    Fabio Matrone
    Roberto Bortolus
    Giulio Francolini
    Beatrice Detti
    Alessandro Magli
    Marco Lorenzo Bonù
    Gianluca Ingrosso
    Andrea Lancia
    Fabio Trippa
    Ernesto Maranzano
    Ciro Franzese
    Paolo Ghirardelli
    Vittorio Vavassori
    Marta Scorsetti
    Filippo Alongi
    Stefano Maria Magrini
    Medical Oncology, 2021, 38
  • [5] Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Not All That Glitters Is Gold
    Briganti, Alberto
    Gandaglia, Giorgio
    Montorsi, Francesco
    JAMA ONCOLOGY, 2020, 6 (10) : 1638 - 1639
  • [6] Oligorecurrent prostate cancer treated with metastasis-directed therapy: oncological outcomes
    Devos, G.
    Berghen, C.
    Joniau, S.
    Poels, K.
    Haustermans, K.
    Rans, K.
    De Meerleer, G.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S633 - S633
  • [7] Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer
    Spencer, Katie L.
    Tree, Alison C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 927 - 929
  • [8] Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Not All That Glitters Is Gold Reply
    Tran, Phuoc T.
    Deek, Matthew P.
    Phillips, Ryan M.
    JAMA ONCOLOGY, 2020, 6 (10) : 1639 - 1639
  • [9] Metastasis-directed therapy for oligorecurrent prostate cancer: A pooled analysis of prospective trials
    Ost, P.
    Alejandro, B.
    Siva, S.
    Reynders, D.
    Phillips, R. M.
    Glicksman, R.
    Foroudi, F.
    Fonteyne, V.
    Deek, M. P.
    Chung, P.
    Murphy, D.
    Tran, P. T.
    EUROPEAN UROLOGY, 2021, 79 : S1175 - S1175
  • [10] Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer
    Deek, Matthew P.
    Sutera, Philip
    Jing, Yuezhou
    Gao, Robert
    Rothman, Emily
    Day, Heather
    Chang, David
    Dirix, Piet
    Armstrong, Andrew J.
    Campbell, Bethany
    Campos, Fernando Lopez
    Berenguer, Miguel
    Ramotar, Matthew
    Conde-Moreno, Antonio
    Berlin, Alejandro
    Bosetti, Davide Giovanni
    Corcoran, Niall
    Koontz, Bridget
    Mercier, Carole
    Siva, Shankar
    Pryor, David
    Ost, Piet
    Huynh, Mai Anh
    Kroeze, Stephanie
    Stish, Bradley
    Kiess, Ana
    Trock, Bruce
    Tran, Phuoc T.
    Gillessen, Silke
    Sweeney, Christopher
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (06): : 1403 - 1410
12345